Audiologic threshold monitoring of patients receiving ototoxic drugs. Preliminary report

W. L. Meyerhoff, Mary W Yellin, G. E. Maale, P. S. Roland

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

An effort was made to determine the efficacy of auditory threshold monitoring of patients receiving ototoxic drugs. Forty-four patients treated with either tobramycin or vancomycin for osteomyelitis were tested at the beginning of treatment, following treatment, and twice weekly during treatment when possible. All patients had renal function carefully monitored. Peak and trough drug levels were kept out of the toxic range throughout the study. In no patient did indisputable ototoxicity occur, and therefore, no conclusion about the most efficacious schedule for auditory monitoring of patients receiving ototoxic drugs was made, and what constitutes a significant intratherapeutic threshold shift is still in question. Until further data are collected, monitoring of renal function and peak and trough drug levels, as well as patient counseling, is recommended. Pretherapy and posttherapy auditory monitoring and intratherapeutic monitoring of high-risk patients and those who develop aural symptoms may prove beneficial.

Original languageEnglish (US)
Pages (from-to)950-954
Number of pages5
JournalAnnals of Otology, Rhinology and Laryngology
Volume98
Issue number12 I
StatePublished - 1989
Externally publishedYes

Fingerprint

Physiologic Monitoring
Pharmaceutical Preparations
Auditory Threshold
Kidney
Tobramycin
Poisons
Osteomyelitis
Vancomycin
Ear
Counseling
Appointments and Schedules
Therapeutics

Keywords

  • Ototoxicity
  • peak and trough levels
  • renal function

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Audiologic threshold monitoring of patients receiving ototoxic drugs. Preliminary report. / Meyerhoff, W. L.; Yellin, Mary W; Maale, G. E.; Roland, P. S.

In: Annals of Otology, Rhinology and Laryngology, Vol. 98, No. 12 I, 1989, p. 950-954.

Research output: Contribution to journalArticle

@article{443d318dfeed4b5592c7a6e16d09473d,
title = "Audiologic threshold monitoring of patients receiving ototoxic drugs. Preliminary report",
abstract = "An effort was made to determine the efficacy of auditory threshold monitoring of patients receiving ototoxic drugs. Forty-four patients treated with either tobramycin or vancomycin for osteomyelitis were tested at the beginning of treatment, following treatment, and twice weekly during treatment when possible. All patients had renal function carefully monitored. Peak and trough drug levels were kept out of the toxic range throughout the study. In no patient did indisputable ototoxicity occur, and therefore, no conclusion about the most efficacious schedule for auditory monitoring of patients receiving ototoxic drugs was made, and what constitutes a significant intratherapeutic threshold shift is still in question. Until further data are collected, monitoring of renal function and peak and trough drug levels, as well as patient counseling, is recommended. Pretherapy and posttherapy auditory monitoring and intratherapeutic monitoring of high-risk patients and those who develop aural symptoms may prove beneficial.",
keywords = "Ototoxicity, peak and trough levels, renal function",
author = "Meyerhoff, {W. L.} and Yellin, {Mary W} and Maale, {G. E.} and Roland, {P. S.}",
year = "1989",
language = "English (US)",
volume = "98",
pages = "950--954",
journal = "Annals of Otology, Rhinology and Laryngology",
issn = "0003-4894",
publisher = "Annals Publishing Company",
number = "12 I",

}

TY - JOUR

T1 - Audiologic threshold monitoring of patients receiving ototoxic drugs. Preliminary report

AU - Meyerhoff, W. L.

AU - Yellin, Mary W

AU - Maale, G. E.

AU - Roland, P. S.

PY - 1989

Y1 - 1989

N2 - An effort was made to determine the efficacy of auditory threshold monitoring of patients receiving ototoxic drugs. Forty-four patients treated with either tobramycin or vancomycin for osteomyelitis were tested at the beginning of treatment, following treatment, and twice weekly during treatment when possible. All patients had renal function carefully monitored. Peak and trough drug levels were kept out of the toxic range throughout the study. In no patient did indisputable ototoxicity occur, and therefore, no conclusion about the most efficacious schedule for auditory monitoring of patients receiving ototoxic drugs was made, and what constitutes a significant intratherapeutic threshold shift is still in question. Until further data are collected, monitoring of renal function and peak and trough drug levels, as well as patient counseling, is recommended. Pretherapy and posttherapy auditory monitoring and intratherapeutic monitoring of high-risk patients and those who develop aural symptoms may prove beneficial.

AB - An effort was made to determine the efficacy of auditory threshold monitoring of patients receiving ototoxic drugs. Forty-four patients treated with either tobramycin or vancomycin for osteomyelitis were tested at the beginning of treatment, following treatment, and twice weekly during treatment when possible. All patients had renal function carefully monitored. Peak and trough drug levels were kept out of the toxic range throughout the study. In no patient did indisputable ototoxicity occur, and therefore, no conclusion about the most efficacious schedule for auditory monitoring of patients receiving ototoxic drugs was made, and what constitutes a significant intratherapeutic threshold shift is still in question. Until further data are collected, monitoring of renal function and peak and trough drug levels, as well as patient counseling, is recommended. Pretherapy and posttherapy auditory monitoring and intratherapeutic monitoring of high-risk patients and those who develop aural symptoms may prove beneficial.

KW - Ototoxicity

KW - peak and trough levels

KW - renal function

UR - http://www.scopus.com/inward/record.url?scp=0024798229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024798229&partnerID=8YFLogxK

M3 - Article

VL - 98

SP - 950

EP - 954

JO - Annals of Otology, Rhinology and Laryngology

JF - Annals of Otology, Rhinology and Laryngology

SN - 0003-4894

IS - 12 I

ER -